dehydroepiandrosterone has been researched along with Angiogenesis, Pathologic in 5 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Metformin has been introduced in the treatment of PCOS to manage insulin resistance and hyperglycemia." | 7.81 | Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model. ( Abramovich, D; Bas, D; Bianchi, MS; Di Pietro, M; Irusta, G; Parborell, F; Pascuali, N; Tesone, M, 2015) |
| " Metformin has been introduced in the treatment of PCOS to manage insulin resistance and hyperglycemia." | 3.81 | Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model. ( Abramovich, D; Bas, D; Bianchi, MS; Di Pietro, M; Irusta, G; Parborell, F; Pascuali, N; Tesone, M, 2015) |
| "Kidney cancer is the sixth most common cancer in the United States, and its incidence is increasing." | 1.43 | Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy. ( Hammock, BD; Kim, J; Ulu, A; Wan, D; Weiss, RH; Yang, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Pietro, M | 1 |
| Parborell, F | 2 |
| Irusta, G | 2 |
| Pascuali, N | 1 |
| Bas, D | 2 |
| Bianchi, MS | 1 |
| Tesone, M | 2 |
| Abramovich, D | 2 |
| Kim, J | 1 |
| Ulu, A | 1 |
| Wan, D | 1 |
| Yang, J | 1 |
| Hammock, BD | 1 |
| Weiss, RH | 1 |
| Howgate, DJ | 1 |
| Gamie, Z | 1 |
| Panteliadis, P | 1 |
| Bhalla, A | 1 |
| Mantalaris, A | 1 |
| Tsiridis, E | 1 |
| Lowin, T | 1 |
| Weidler, C | 1 |
| Jenei-Lanzl, Z | 1 |
| Capellino, S | 1 |
| Baerwald, CG | 1 |
| Buttgereit, F | 1 |
| Straub, RH | 1 |
| Cataldi, NI | 1 |
1 review available for dehydroepiandrosterone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence.
Topics: Adipose Tissue; Aged; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Bre | 2009 |
4 other studies available for dehydroepiandrosterone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model.
Topics: Angiogenesis Modulating Agents; Angiopoietin-1; Angiopoietin-2; Animals; Dehydroepiandrosterone; Fem | 2015 |
Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Cell Line, Tumor; Cytochrome P-450 Enzyme Syst | 2016 |
Relationship between placenta growth factor 1 and vascularization, dehydroepiandrosterone sulfate to dehydroepiandrosterone conversion, or aromatase expression in patients with rheumatoid arthritis and patients with osteoarthritis.
Topics: Aged; Aromatase; Arthritis, Rheumatoid; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fema | 2012 |
Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Topics: Adjuvants, Immunologic; Angiopoietins; Animals; Dehydroepiandrosterone; Disease Models, Animal; Endo | 2012 |